Lymphoma, B-Cell Clinical Trials

A listing of Lymphoma, B-Cell medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

UPDATED

Birmingham Alabama 35211

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

California

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

UPDATED

Los Angeles California 90095

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

UPDATED

Palo Alto California 94304

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

UPDATED

Denver Colorado 80218

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

Connecticut

UPDATED

New Haven Connecticut 06510

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

Florida

UPDATED

Tampa Florida 33612-9497

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

Georgia

UPDATED

Atlanta Georgia 30342

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

Illinois

UPDATED

Chicago Illinois 60611

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

UPDATED

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Blinatumomab and Investigator's Choice Chemotherapy to evaluate High-risk Diffuse Large B-Cell Lymphoma (DLBCL)

UPDATED

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

UPDATED

Urbana Illinois 61801

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

Iowa

UPDATED

Ames Iowa 50010

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

Maryland

UPDATED

Lutherville Maryland 21093

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

Massachusetts

UPDATED

Boston Massachusetts 02215

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

UPDATED

Boston Massachusetts 02114

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

UPDATED

Boston Massachusetts 02114

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

Michigan

UPDATED

Grand Rapids Michigan 49503

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

Minnesota

UPDATED

Minneapolis Minnesota 55407

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

Mississippi

UPDATED

Jackson Mississippi 39216

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

Missouri

UPDATED

St. Louis Missouri 63110

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

Nebraska

UPDATED

Omaha Nebraska 10065

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

New Jersey

UPDATED

Basking Ridge New Jersey 07920

Patients are needed to participate in a clinical research study evaluating Buparlisib and Ibrutinib for the treatment of Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma or Diffuse Large B Cell Lymphoma

UPDATED

Middletown New Jersey 07748

Patients are needed to participate in a clinical research study evaluating Buparlisib and Ibrutinib for the treatment of Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma or Diffuse Large B Cell Lymphoma

UPDATED

New Brunswick New Jersey 08903

Patients are needed to participate in a clinical research study of Blinatumomab and Investigator's Choice Chemotherapy to evaluate High-risk Diffuse Large B-Cell Lymphoma (DLBCL)

New York

UPDATED

Commack New York 11725

Patients are needed to participate in a clinical research study evaluating Buparlisib and Ibrutinib for the treatment of Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma or Diffuse Large B Cell Lymphoma

UPDATED

Harrison New York 10604

Patients are needed to participate in a clinical research study evaluating Buparlisib and Ibrutinib for the treatment of Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma or Diffuse Large B Cell Lymphoma

UPDATED

New York New York 10065

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study evaluating Buparlisib and Ibrutinib for the treatment of Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma or Diffuse Large B Cell Lymphoma

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

View More ▼

UPDATED

New York New York 10016

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

UPDATED

Rockville Centre New York 11570

Patients are needed to participate in a clinical research study evaluating Buparlisib and Ibrutinib for the treatment of Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma or Diffuse Large B Cell Lymphoma

North Carolina

UPDATED

Charlotte North Carolina 28204

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

UPDATED

Winston-Salem North Carolina 27103

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

Ohio

UPDATED

Cleveland Ohio 44195

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

UPDATED

Columbus Ohio 43210

A clinical trial to evaluate treatments using Lenalidomide, Obinutuzumab and Venetoclax for patients

Oklahoma

UPDATED

Oklahoma City Oklahoma 73104

Patients are needed to participate in a clinical research study of Blinatumomab and Investigator's Choice Chemotherapy to evaluate High-risk Diffuse Large B-Cell Lymphoma (DLBCL)

Oregon

UPDATED

Portland Oregon 97239

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

UPDATED

Portland Oregon 97213

Patients are needed to participate in a clinical research study of Blinatumomab and Investigator's Choice Chemotherapy to evaluate High-risk Diffuse Large B-Cell Lymphoma (DLBCL)

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19104

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

UPDATED

Philadelphia Pennsylvania 19111

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

UPDATED

Pittsburgh Pennsylvania 15232

A clinical trial to evaluate treatments using JCAR017 single-dose schedule and JCAR017 2-dose schedule for patients with Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma or Mantle-cell Lymphoma

UPDATED

Pittsburgh Pennsylvania 15213

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)

South Carolina

UPDATED

Greenville South Carolina 29607

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma

UPDATED

Greenville South Carolina 29607

Patients are needed to participate in a clinical research study of Blinatumomab and Investigator's Choice Chemotherapy to evaluate High-risk Diffuse Large B-Cell Lymphoma (DLBCL)

UPDATED

Spartanburg South Carolina 29303

A Phase 2 clinical study for patients with Adult Diffuse Large B-Cell Lymphoma or B-cell Non-Hodgkin's Lymphoma